Literature DB >> 26129972

Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumannii.

Tugba Arslan Gulen1, Rahmet Guner2, Nevreste Celikbilek3, Siran Keske4, Mehmet Tasyaran2.   

Abstract

BACKGROUND: A. baumannii is an important nosocomial pathogen associated with high mortality, morbidity and medical cost. AIM: The aim of this study was to investigate risk factors for MDR A. baumannii bacteremia and also evaluate cost of hospitalization of these patients.
METHODS: Study was conducted in Ankara Atatürk Training and Research Hospital. Patients who were hospitalized in ICU and diagnosed for nosocomial blood stream infection (BSI) between January 2007 and December 2010 were checked retrospectively. Patients with nosocomial BSI caused by multidrug resistant A. baumannii were compared with the patients who had BSI caused by other Gram-negative microorganisms in terms of risk factors, mortality and medical costs.
FINDINGS: In multivariate analysis previous use of carbapenem, quinolone and metronidazole, and SAPS II score were found as independent risk factors. In case group; immunosupression, SAPS II score, and hospital stay until infection were independently associated with mortality in multivariate analysis.
CONCLUSION: Our results suggest that the occurrence of MDR A.baumannii bacteremia was related with the usage of the wide spectrum antibiotics, and mortality rates were increased in patients that high SAPS II scores, long term hospitalization. Infection control procedures and limited antibiotic usage are very important for prevent nosocomial infections.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; cost; multi-drug resistance

Mesh:

Year:  2015        PMID: 26129972     DOI: 10.1016/j.ijid.2015.06.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  23 in total

1.  Morbidity and mortality risk factors in emergency department patients with Acinetobacter baumannii bacteremia.

Authors:  Rui-Xue Sun; Priscilla Song; Joseph Walline; He Wang; Ying-Chun Xu; Hua-Dong Zhu; Xue-Zhong Yu; Jun Xu
Journal:  World J Emerg Med       Date:  2020

2.  Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.

Authors:  Sarah Ainsworth; Patrick M Ketter; Jieh-Juen Yu; Rose C Grimm; Holly C May; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2017-05-15       Impact factor: 3.641

3.  Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents.

Authors:  Tingting Zhang; Min Wang; Yixin Xie; Xianping Li; Zhihui Dong; Yanhua Liu; Ling Wang; Min Yang; Huan Song; Hong Cao; Wei Cao
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

4.  Comparison of Cefepime-Cefpirome and Carbapenem Therapy for Acinetobacter Bloodstream Infection in a Multicenter Study.

Authors:  Yea-Yuan Chang; Ya-Sung Yang; Shang-Liang Wu; Yung-Chih Wang; Te-Li Chen; Yi-Tzu Lee
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

5.  In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China.

Authors:  Tao Li; Meiyan Sheng; Tengzhen Gu; Yan Zhang; Ailiyaer Yirepanjiang; Yu Li
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

6.  Inappropriate Antibiotic Use Among Inpatients Attending Madda Walabu University Goba Referral Hospital, Southeast Ethiopia: Implication for Future Use.

Authors:  Mohammedaman Mama; Ayele Mamo; Heyder Usman; Bedru Hussen; Abduljewad Hussen; Geroma Morka
Journal:  Infect Drug Resist       Date:  2020-05-12       Impact factor: 4.003

7.  Antibacterial Activity of Rosmarinus officinalis against Multidrug-Resistant Clinical Isolates and Meat-Borne Pathogens.

Authors:  Aseer Manilal; Kuzhunellil Raghavanpillai Sabu; Melat Woldemariam; Addis Aklilu; Gelila Biresaw; Tsegaye Yohanes; Mohammed Seid; Behailu Merdekios
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-29       Impact factor: 2.629

8.  Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice.

Authors:  Tadasu Iizumi; Takako Taniguchi; Wataru Yamazaki; Geraldine Vilmen; Alexander V Alekseyenko; Zhan Gao; Guillermo I Perez Perez; Martin J Blaser
Journal:  Gut Pathog       Date:  2016-11-18       Impact factor: 4.181

Review 9.  Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis.

Authors:  Raspail Carrel Founou; Luria Leslie Founou; Sabiha Yusuf Essack
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

10.  Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil.

Authors:  Bruna Fuga Araujo; Melina Lorraine Ferreira; Paola Amaral de Campos; Sabrina Royer; Deivid William da Fonseca Batistão; Raquel Cristina Cavalcanti Dantas; Iara Rossi Gonçalves; Ana Luiza Souza Faria; Cristiane Silveira de Brito; Jonny Yokosawa; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.